Press Announcements
Note: Press announcements from 2004 to 2014 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
UPDATE: The FDA is moving to a new email subscription and delivery service. The link to subscribe will be available again soon. Thank you for your patience.
January 2018
- January 30, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help prevent new addiction, curb abuse and overdose related to opioid products
- January 30, 2018 - FDA, USDA announce formal agreement to bolster coordination and collaboration
- January 26, 2018 - FDA approves new treatment for certain digestive tract cancers
- January 26, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s strengthened commitments to humane and judicious animal research and the termination of a nicotine study
- January 24, 2018 - FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims
- January 18, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy steps for strengthening public warning and notification of recalls
- January 16, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review
- January 16, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. responding to report from GAO and updating on FDA’s ongoing efforts to increase access to complex generic drugs
- January 16, 2018 - FDA Commissioner Scott Gottlieb, M.D., updates on some ongoing shortages related to IV fluids
- January 16, 2018 - FDA and DoD launch program to expedite availability of medical products for the emergency care of American military personnel
- January 16, 2018 - FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs
- January 12, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products
- January 12, 2018 - FDA approves first treatment for breast cancer with a certain inherited genetic mutation
- January 11, 2018 - FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
- January 11, 2018 - FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use
- January 04, 2018 - Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages
- January 04, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA Food Safety Modernization Act enforcement discretion guidance
- January 04, 2018 - FDA warns American CryoStem Corporation of significant deviations related to its unapproved stem cell product, Atcell
- January 03, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices
- Previous
- 1
